XML 25 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statement of Cash Flows (Unaudited) - Williams - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES:    
Net income (loss) $ 1,788 $ 1,312
Adjustments to reconcile to net cash provided (used) by operating activities:    
Depreciation, depletion, and amortization 1,176 1,190
Provision (benefit) for deferred income taxes 492 186
Equity (earnings) losses (320) (297)
Distributions from equity-method investees 448 412
Gain on sale of certain assets (Note 3) (194) 0
Net unrealized (gain) loss from commodity derivative instruments 83 (4)
Gain on disposition of equity-method investments (Note 3) (127) 0
Inventory write-downs 12 4
Amortization of stock-based awards 39 49
Cash provided (used) by changes in current assets and liabilities:    
Accounts receivable 106 301
Inventories (32) (61)
Other current assets and deferred charges (23) (36)
Accounts payable (240) (265)
Other current liabilities (58) 150
Changes in current and noncurrent commodity derivative assets and liabilities (56) 19
Other, including changes in noncurrent assets and liabilities (115) (77)
Net cash provided (used) by operating activities 2,979 2,883
FINANCING ACTIVITIES:    
Proceeds from (payments of) commercial paper – net (224) (454)
Proceeds from long-term debt 2,790 2,994
Payments of long-term debt (1,119) (975)
Payments for debt issuance costs (33) (26)
Proceeds from issuance of common stock 8 5
Common dividends paid (1,284) (1,221)
Dividends and distributions paid to noncontrolling interests (140) (131)
Contributions from noncontrolling interests 32 19
Other – net (79) (57)
Net cash provided (used) by financing activities (49) 154
INVESTING ACTIVITIES:    
Capital expenditures (1) (3,193) (1,984)
Dispositions – net (Note 3) 345 (40)
Proceeds from sale of business (Note 7) 48 0
Proceeds from disposition of equity-method investments (Note 3) 6 0
Purchases of and contributions to equity-method investments (91) (179)
Other – net 95 9
Net cash provided (used) by investing activities (2,790) (2,194)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total 140 843
Cash and cash equivalents at beginning of year 63 60
Cash and cash equivalents at end of period 203 903
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]    
(1) Increases to property, plant, and equipment (3,347) (2,041)
Changes in related accounts payable and accrued liabilities 154 57
Capital expenditures $ (3,193) $ (1,984)